Your browser doesn't support javascript.
loading
VEXAS syndrome: A new mimicker of idiopathic multicentric Castleman disease.
Philip, Rémi; Cadro, Vincent; Aouba, Achille; Chantepie, Sylvain; Bracquemart, Claire; Dumont, Anaël.
Afiliação
  • Philip R; Department of Clinical Immunology and Internal Medicine, Caen University Hospital, 14000 Caen, France; Normandie University, UNICAEN, Caen University Hospital, 14000 Caen, France. Electronic address: remi.philip.okb@gmail.com.
  • Cadro V; Normandie University, UNICAEN, CHU de Caen Normandie, Structure Fédérative d'Oncogénétique cyto-moléculaire (MOCAE), 14000 Caen, France.
  • Aouba A; Department of Clinical Immunology and Internal Medicine, Caen University Hospital, 14000 Caen, France; Normandie University, UNICAEN, Caen University Hospital, 14000 Caen, France.
  • Chantepie S; Department of Haematology, Caen University Hospital, 14000 Caen, France.
  • Bracquemart C; Normandie University, UNICAEN, CHU de Caen Normandie, Structure Fédérative d'Oncogénétique cyto-moléculaire (MOCAE), 14000 Caen, France.
  • Dumont A; Department of Clinical Immunology and Internal Medicine, Caen University Hospital, 14000 Caen, France.
Joint Bone Spine ; 91(4): 105731, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38583690
ABSTRACT

INTRODUCTION:

Idiopathic Multicentric Castleman Disease (iMCD) is a complex and poorly understood pathophysiological entity, which encompasses a variety of conditions and can mimic or be associated with autoimmune/autoinflammatory diseases, making it challenging to diagnose and treat. Vacuoles, Enzyme E1, X-linked, Autoinflammatory, Somatic (VEXAS) syndrome is an adult-onset autoinflammatory disorder associated with hematological abnormalities and caused by acquired somatic mutations in the ubiquitin-like modifier activating enzyme 1 gene (UBA1) which shares several common clinical and biological signs with iMCD. In this article, we report a patient with VEXAS syndrome initially presenting as iMCD, questioning the link between these two entities. CASE DESCRIPTION We report here a patient initially presenting as iMCD, proved on lymph node histology, which turns out to have a mutation at the splice acceptor site of exon 3 of UBA1 exhibiting VEXAS syndrome with Castleman-like lymph node.

CONCLUSION:

This is only the second case of VEXAS syndrome presenting as iMCD. VEXAS syndrome should therefore be considered in the presence of iMCD suspicion, including in cases of compatible histology.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante / Enzimas Ativadoras de Ubiquitina Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Joint Bone Spine Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante / Enzimas Ativadoras de Ubiquitina Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Joint Bone Spine Ano de publicação: 2024 Tipo de documento: Article